Breaking News
Subscribe Now 0
💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair Value See Undervalued Stocks

Search Results for "treatment":

Results: 33,779

Quotes

THNR Amplify Weight Loss Drug & Treatment ETF ETF - NYSE etf 8996 Kaori Heat Treatment Co Ltd Stock - Taiwan equities 600187 Heilongjiang Interchina Water Treatment Co Ltd Stock - Shanghai equities 605069 Beijing ZEHO Waterfront Ecological Environment Treatment Co Ltd Stock - Shanghai equities 3768 Kunming Dianchi Water Treatment Co Ltd Stock - Hong Kong equities TRUE Treatment.com International Inc Stock - CSE equities 476070 Samsung KODEX Global Obesity Treatment Top2 Plus ETF ETF - Seoul etf 476690 MiraeAsset TIGER Global Obesity Treatment Top2 Plus ETF ETF - Seoul etf
Show all (9)

News

US FDA approves Zevra's genetic disorder treatment
By Reuters

(Reuters) - The U.S. Food and Drug Administration approved Zevra Therapeutics' drug for a rare and fatal genetic disorder, the first treatment to get a nod for the condition, the health regulator...

Cytokinetics shares hold buy rating on HCM treatment promise
By Investing.com

On Friday, H.C. Wainwright maintained a positive outlook on Cytokinetics (NASDAQ:CYTK) shares, reiterating a Buy rating and a $90.00 price target. The firm's optimism is rooted in the potential of...

FDA approves first Niemann-Pick type C disease treatment
By Investing.com

CELEBRATION, Fla. - Zevra Therapeutics, Inc. (NasdaqGS: ZVRA), a rare disease therapeutics company, announced today the FDA approval of MIPLYFFA (arimoclomol) for Niemann-Pick disease type C (NPC)....

Show all (28,794)

Analysis

10 Undervalued Stocks Under $10 With Massive Upside Potential
By Jesse Cohen

Investing in cheap undervalued stocks priced under $10 can offer potential growth without the need for significant capital. Using the Investing.com 'Under $10/Share' stock screener, I searched for...

Theraclion: Faster Treatment Opens Market
By Edison

Faster treatment opens marketTheraclion (PA:ALTHER) has announced interim clinical results on a crucial innovation, Beamotion, to speed up EchoPulse therapy five times. The CE-marked EchoPulse device...

Fluence Corporation: Time For Better Treatment?
By Edison

If Fluence Corporation Ltd (AX:FLC) can deliver on its H218e target, its shares could re-rate sharply. Its membrane-aerated biofilm reactor (MABR) technology provides a competitive advantage in the...

Show all (4,976)
Results: 9

Refine Results

Instrument Type

Region

 

Country

Exchange

Sector

 

Industry

 
Results: 28,794

Refine Results

Date

Date
 

Category

Provider

 

News

{{title}}
By {{provider}}

{{content}}

Please try another search

Results: 4,976

Refine Results

Date

Date
 

Category

Author

Analysis

{{title}}
By {{provider}}

{{content}}

Results: 0

Refine Results

Country

Importance

Economic Events

Results: 0

Tools & Sections

Results: 0

Authors

Continue with Apple
Continue with Google
or
Sign up with Email